An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination

Int J Infect Dis. 2022 Aug:121:98-101. doi: 10.1016/j.ijid.2022.04.057. Epub 2022 Apr 30.

Abstract

We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea several hours after vaccination with the second dose of mRNA-1273. She was hospitalized on day nine due to worsening dyspnea. Chest computed tomography showed bilateral ground-glass opacities and consolidations, mainly in the peripheral lung areas. Repeat polymerase chain reaction tests for SARS-CoV-2 were negative, although the serum level of antibodies against spike protein was extremely elevated. Her condition did not improve with high-dose corticosteroids and high-flow nasal cannula oxygen therapy; she died on day 18. Autopsy findings revealed very early-phase diffuse alveolar damage in the whole lung without other lung diseases. The clinical and pathological findings suggested vaccine-induced acute respiratory distress syndrome. Serological and pathological tests might be useful to differentiate the disease from COVID-19.

Keywords: COVID-19; acute respiratory distress syndrome; autopsy; vaccine.

Publication types

  • Case Reports

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Aged, 80 and over
  • Autopsy
  • COVID-19 Vaccines / adverse effects
  • COVID-19*
  • Dyspnea
  • Female
  • Humans
  • Respiratory Distress Syndrome* / etiology
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines
  • 2019-nCoV Vaccine mRNA-1273